TickerFacts.

Sinovac Biotech Ltd (SVA): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

71.86M
As of 2025-12-31
+0.1%
3-year compound annual growth
99.29M2010-12-31: 54.31M2011-12-31: 54.77M2012-12-31: 55.09M2013-12-31: 55.57M2014-12-31: 55.81M2015-12-31: 56.91M2016-12-31: 57.01M2017-12-31: 57.28M2018-12-31: 71.14M2019-12-31: 98.90M2020-12-31: 99.29M2021-12-31: 71.72M2022-12-31: 71.72M2023-12-31: 71.86M2024-12-31: 71.86M2025-12-31: 71.86M71.86M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3171.86M0.0%2026-06-05, Balance as of period end
2024-12-3171.86M0.0%2026-06-05, Balance as of period end
2023-12-3171.86M+0.2%2026-04-30, Balance as of period end
2022-12-3171.72M0.0%2026-04-30, Balance as of period end
2021-12-3171.72Mn/c2026-04-30, Balance as of period end
2020-12-3199.29M+0.4%2022-04-29, Balance as of period end
2019-12-3198.90M+39.0%2021-04-22, Balance as of period end
2018-12-3171.14M+24.2%2020-04-30, Balance as of period end
2017-12-3157.28M+0.5%2019-04-29, Balance as of period end
2016-12-3157.01M+0.2%2018-05-11, Balance as of period end
2015-12-3156.91M+2.0%2017-11-22, Balance as of period end
2014-12-3155.81M+0.4%2016-04-25, Balance as of period end
2013-12-3155.57M+0.9%2015-04-29, Balance as of period end
2012-12-3155.09M+0.6%2014-04-16, Balance as of period end
2011-12-3154.77M+0.9%2013-05-23, Balance as of period end
2010-12-3154.31Mn/a2012-04-12, Balance as of period end